Biodesix Return On Equity from 2010 to 2024

BDSX Stock  USD 1.43  0.01  0.69%   
Biodesix Return On Equity yearly trend continues to be fairly stable with very little volatility. Return On Equity is likely to outpace its year average in 2024. Return On Equity is a measure of the profitability of Biodesix in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(11.39)
Current Value
(10.82)
Quarterly Volatility
3.92788126
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.5 M, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0 or PTB Ratio of 34.64. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
  
Check out the analysis of Biodesix Correlation against competitors.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Latest Biodesix's Return On Equity Growth Pattern

Below is the plot of the Return On Equity of Biodesix over the last few years. Return on Equity is the amount of Biodesix net income returned as a percentage of Biodesix equity. Return on equity measures Biodesix profitability by revealing how much profit Biodesix generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Biodesix's Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biodesix's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported -3.3210 Years Trend
Slightly volatile
   Return On Equity   
       Timeline  

Biodesix Return On Equity Regression Statistics

Arithmetic Mean(1.86)
Coefficient Of Variation(211.02)
Mean Deviation2.79
Median0.13
Standard Deviation3.93
Sample Variance15.43
Range11.5228
R-Value(0.73)
Mean Square Error7.86
R-Squared0.53
Significance0
Slope(0.64)
Total Sum of Squares216.00

Biodesix Return On Equity History

2024 -10.82
2023 -11.39
2022 -3.9
2021 -2.25
2020 -0.89
2019 0.14

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's Return On Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Equity(11.39)(10.82)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.